Korean J Pain.  2017 Jan;30(1):18-33. 10.3344/kjp.2017.30.1.18.

Guidelines for prescribing opioids for chronic non-cancer pain in Korea

• Kim ED
• Lee JY
• Son JS
• Byeon GJ
• Yeo JS
• Kim DW
• Yoo SH
• Hong JH
• Park HJ
• Opioids Research Group in the Korean Pain Society

• KMID: 2365338
• DOI: http://doi.org/10.3344/kjp.2017.30.1.18

Abstract

As the treatment of chronic non-cancer pain gradually increases, clinicians have more opportunities to encounter opioid prescription. However, guidelines for prescribing opioids for chronic non-cancer pain have never been published in Korea. The present guidelines were prepared by reviewing various research data. In cases in which the data were insufficient, recommendations were presented following discussion among experts affiliated with the Opioids Research Group in the Korean Pain Society. The present guidelines may need to be continuously revised and amended as more clinical evidence is acquired.

Keyword

Addiction; Adverse effect; Assessment; Dependency; Equivalent dose; Non-cancer pain; Opioid; Opioid rotation

MeSH Terms

Analgesics, Opioid*
Korea*
Prescriptions
Analgesics, Opioid

Figure

• 

  Fig. 1 Example of a written consent form regarding the prescription of opioids for the treatment of chronic non-cancer pain [4].

• 

  Fig. 2 Stepwise approach to the choice of opioids [10].

• 

  Fig. 3 Schematic diagram of opioid rotation.

Reference

1. Paone D, Dowell D, Heller D. Preventing misuse of prescription opioid drugs. City Health Inf. 2011; 30:23–30.

2. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005; 6:432–442. PMID: 16336480.

3. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2--guidance. Pain Physician. 2012; 15:S67–S116. PMID: 22786449.

4. The Committee for the Guidelines for Prescribing Opioid Analgesics for Chronic Non-cancer Pain of JSPC. Guidelines for prescribing opioid analgesics for chronic non-cancer pain. Tokyo: Shinko Trading Press;2012. p. 68–131.

5. Webster LR, Dove B. Avoiding opioid abuse while managing pain: a guide for practitioners. North Branch (MIN): Sunrise River Press;2007.

6. Yamaguchi T, Shima Y, Morita T, Hosoya M, Matoba M. Japanese Society of Palliative Medicine. Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations. Jpn J Clin Oncol. 2013; 43:896–909. PMID: 23885114.

7. Hwang IC, Shim JY. Opioids use for chronic noncancer pain. J Korean Med Assoc. 2013; 56:711–717.

8. Lee SY, Sohn KM, Ryu JY, Yoon YR, Shin JG, Kim JW. Sequence-based CYP2D6 genotyping in the Korean population. Ther Drug Monit. 2006; 28:382–387. PMID: 16778723.

9. Ko Y, Kim YH. The pharmacological management of neuropathic pain. J Korean Med Assoc. 2012; 55:582–592.

10. National Opioid Use Guideline Group (CA). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain [Internet]. Ontario: Michael G. DeGroote National Pain Centre;2010. cited 2016 Oct 5. Available at http://nationalpaincentre.mcmaster.ca/opioid/.

11. Sansone RA, Sansone LA. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 2009; 6:17–21.

12. Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain. 2010; 23:99–108. PMID: 20556211.

13. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10:113–130. PMID: 19187889.

14. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016; 315:1624–1645. PMID: 26977696.

15. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005; 293:3043–3052. PMID: 15972567.

16. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010; CD006605. PMID: 20091598.

17. Ma K, Jiang W, Zhou Q, Du DP. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. Int J Clin Pract. 2008; 62:241–247. PMID: 18070045.

18. Lemming D, Sörensen J, Graven-Nielsen T, Arendt-Nielsen L, Gerdle B. The responses to pharmacological challenges and experimental pain in patients with chronic whiplash-associated pain. Clin J Pain. 2005; 21:412–421. PMID: 16093747.

19. Lee WH. Use of opioid analgesics for the management of chronic noncancer pain. J Korean Pain Soc. 2004; 17(Suppl):S88–S93.

20. Geppetti P, Benemei S. Pain treatment with opioids: achieving the minimal effective and the minimal interacting dose. Clin Drug Investig. 2009; 29(Suppl 1):3–16.

21. Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A. National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Physician. 2011; 57:1269–1276. e419–e428. PMID: 22084456.

22. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996; 347:143–147. PMID: 8544547.

23. Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev. 2011; 30:264–270. PMID: 21545556.

24. Cho YS, Lee JY, Kim HS, Kwon JH. Trends in the consumption of opioid analgesics in a tertiary care hospital from 2000 to 2012. Yakhak Hoeji. 2014; 58:268–276.

25. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013; 62:537–542. PMID: 23820967.

26. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305:1315–1321. PMID: 21467284.

27. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011; 171:686–691. PMID: 21482846.

28. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003; 349:1943–1953. PMID: 14614170.

29. Brennan MJ. The clinical implications of cytochrome p450 interactions with opioids and strategies for pain management. J Pain Symptom Manage. 2012; 44:S15–S22. PMID: 23218232.

30. Vissers KC, Besse K, Hans G, Devulder J, Morlion B. Opioid rotation in the management of chronic pain: where is the evidence? Pain Pract. 2010; 10:85–93. PMID: 20070552.

31. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013; 170:834–851. PMID: 23903334.

32. Degenhardt L, Bruno R, Lintzeris N, Hall W, Nielsen S, Larance B, et al. Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study. Lancet Psychiatry. 2015; 2:314–322. PMID: 26360084.

33. Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med. 2011; 26:958–964. PMID: 21347877.

34. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006; 9:57–60. PMID: 16700282.

35. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008; 24:497–508. PMID: 18574359.